In this exclusive video interview, James Del Rosso, DO, gets into the details of JAK inhibitors, explaining how they work and cutting through the hype around the treatments.
In a video for Dermatology Times®, Mark Lebwohl, MD, details how to match patients with the right psoriasis treatment for their specific needs.
An article published in the Journal of Investigative Dermatology examined genetic, environmental triggers, immunology, pathophysiology, and precision medicine in psoriasis.
A phase 3 study evaluated apremilast as a treatment for patients with mild to moderate psoriasis.
In this video interview, Mark Lebwohl, MD, explains why topicals for inflammatory conditions are vital for treatment.
In this episode, we dive into the background of the “The Full Spectrum of Dermatology: A Diverse and Inclusive Atlas.” Adam Friedman, MD, and Misty Eleryan MD, MS, describe their process to creating this new dermatologic resource.
The study examines the impact of antirheumatic treatment on pregnancy outcomes in women with psoriatic arthritis.
Mark G. Lebwohl, MD, presents on what dermatologists need to know about the newest psoriasis studies during the Fall Clinical Dermatology Conference.
Neal Bhatia, MD, explores steroid alternatives in his presentation at the Fall Clinical Dermatology Conference.